Oncology Articles
Featured Articles
Read our latest stories on the people and scientific innovations making a difference in patients’ lives.
Living Longer with Cancer: Redefining What It Means to Survive
The sixth season of Science Will Win, Pfizer's award-winning podcast, focused on cancer. The six episodes explored the disease from every angle, from its rising incidence in younger populations to the precision medicine tools helping clinicians catch it earlier and treat it more effectively. Host Dr. Raven Baxter delved deep into each topic, interviewing doctors, scientists, researchers, and Pfizer colleagues to glean their insights and discuss the ongoing effort to conquer cancer.To further...
Multiple Myeloma: Shedding Light on a Rare but Complex Blood Cancer
Donna is more than a cancer patient: Donna is a wife, mother, grandmother, sister, and friend who has a full life outside of treatment. Her journey with multiple myeloma has revealed depths of resilience and strength that have long served her in all of those roles.“We have multiple myeloma…but that should not define us,” Donna shared in a recent video interview.It’s a message that Max Merz MD, MHBA, hematologist/oncologist and associate attending physician at Memorial Sloan Kettering Cancer...
May Social Media Round-Up—ASCO, Q1 2026 Results, and More
Summer’s approaching fast, but here at Pfizer the work doesn’t stop. So before you get outside to enjoy the warmer weather, catch up with the latest activity on our social channels.May has been chock full of highlights—from sharing the latest data across our cancer work at ASCO 2026 to a feature in TIME highlighting how we bring science from the lab to life, we’re offering looks behind the science of Pfizer’s research. Next, review Pfizer’s first quarter results, courtesy of CEO Albert Bourla...
Turning Silence Into Advocacy: Women Reshaping Cancer Conversations
The sixth season of Science Will Win, Pfizer’s award-winning podcast, focused on cancer, with each episode tackling a different aspect of the fight against the disease. Host Dr. Raven Baxter delved deep into a variety of topics within oncology, interviewing doctors, scientists, researchers, and Pfizer colleagues to glean their insights and discuss their efforts to eventually conquer cancer.To further the conversation, each of the five podcast episodes was accompanied by a full-length video...
For this Pfizer Scientist, Cancer Research is Personal
For Shuo Wang, cancer research isn’t just a job - it’s personal.Wang, a scientist in Pfizer’s oncology research unit, remembers when one of her close friends was diagnosed with stage four lung cancer shortly after giving birth to her second child. The experience happened early in her career, and deepened Wang’s determination to make a meaningful impact.Wang and her team spend their days planning experiments, analyzing data, and working together to help advance cancer treatments. Along with...
Lung Cancer: Real Risks, Common Myths, and Why Screening Matters
Can you name the top three cancer diagnoses affecting Americans? Did you guess breast (#1), prostate (#2), or colon (#4)? Those are good picks, but there’s another type of cancer that takes the number three spot: lung.1Lung cancer is the third-most diagnosed type of cancer in the country.2 Smoking remains the No. 1 risk factor for developing lung cancer,3 but 10 to 20 percent of lung cancers occur in people who have never smoked before (or who have smoked fewer than 100 cigarettes in their whole...
Pfizer’s New San Diego R&D Hub Accelerates the Next Wave of Cancer Innovation
A state-of-the-art campus designed to turn scientific ambition into breakthroughs for people with cancerFor more than two decades, Pfizer has pushed the boundaries of cancer care, developing medicines that have helped transform treatment for some of the world’s most challenging cancers. That progress continues to fuel an ambition to keep expanding what’s possible – an ambition brought to life in San Diego, where a new state-of-the-art campus has been purpose-built to help advance science and...
Podcast Highlights Pfizer Foundation’s Mission to Improve Breast Cancer Outcomes
For over 75 years, the Pfizer Foundation, a charitable organization, has worked toward the mission of helping build healthier communities around the world. By investing in locally led organizations and applying a community-centered approach, the Foundation aims to address today’s complex global health challenges, respond to urgent health needs, and empower Pfizer colleagues to make a positive impact where they live, work, and beyond.Launched in 2025, The Pfizer Foundation’s Action & Impact...
Making Progress Against Cancer - From Cancer Research to Prevention and Screening
Advances in cancer care often begin with incremental steps in the lab that, over time, have the power to drive transformative breakthroughs. That’s why scientists are working around the clock to develop potential treatments that could help patients live longer, healthier lives. At Pfizer, Sharsti Sandall is one of those scientists.An executive director in Pfizer’s oncology research division, Sandall leads the antibody drug conjugate (ADC) group, which is a targeted treatment that delivers cancer...
How Biomarker Testing Helped a Lung Cancer Patient Get the Treatment She Needed
Earlier this month, Science Will Win, Pfizer’s award-winning podcast, wrapped up another successful season. Launched in February, season 6 included five episodes, each one focused on a different aspect of the fight against cancer, wrapping with last week’s season finale about AI’s impact on cancer care.All season long, each podcast episode has been accompanied by a full-length video conversation between host Dr. Raven Baxter – a molecular biologist and science educator – and one of her guests...
Science Will Win season finale explores AI in cancer care with Pfizer Chief Oncology Officer Jeff Legos
In February, Pfizer launched the sixth season of Science Will Win, our flagship podcast which recently reached 3 million downloads.The season finale focuses on the future of technology and artificial intelligence (AI) —and what they could mean for cancer research and care. Cancer research is moving faster than ever, but that progress is not always reflected in the patient experience. AI may be starting to change that. The last episode of Science Will Win Season 6 follows the human journey, from...
How AI Is Already Reshaping Cancer Care
When treating cancer, few things are more precious than time. Jeanine Bortel, Vice President and Head of AI Portfolio Development at Pfizer, who has developed clinical trials at Pfizer for more than two decades, remembers when she first witnessed the transformative potential of artificial intelligence (AI) put into practice to help address the needs of patients enrolled in cancer clinical trials.For years, Bortel’s work had run up against an inherent challenge: Many cancer patients miss out on...
Media Resources & Contact Information
Anyone may view our press releases, press statements, and press kits. However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer Media Contacts may only respond to calls and emails from professional journalists.